Jasper Therapeutics receives Nasdaq minimum bid price deficiency notice
Jasper Therapeutics received written notice from Nasdaq on June 3, 2026, that its voting common stock bid price had closed below the $1.00 per share minimum…
$1.00180-calendar-dayJune 3, 2026